Beat AML Master Trial

November 30, 2017

Leukemia & Lymphoma Society Invests $46M in Research Funding Worldwide

News

As part of its comprehensive research investment program, the Leukemia & Lymphoma Society (LLS) recently committed $46 million to fund the most innovative science looking for cures for blood cancers at ... Read more

August 9, 2017

Leukemia and Lymphoma Society Is Adding a New Cancer to Its Precision Medicine Program

News

The Leukemia and Lymphoma Society is expanding its innovative precision medicine program to acute myeloid leukemia, or AML. It announced the decision 10 months after it agreed to include an AML trial in ... Read more